|
Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
ISSN: 1596-5996 EISSN: 1596-5996
Vol. 15, No. 1, 2016, pp. 33-38
|
Bioline Code: pr16005
Full paper language: English
Document type: Research Article
Document available free of charge
|
|
Tropical Journal of Pharmaceutical Research, Vol. 15, No. 1, 2016, pp. 33-38
en |
Tricyclic Neovibsanin Scaffold Inhibits Glioma by Targeting Glioma-Initiating Cells
Ding, Peng; Xu, Xi-Miao; Teng, Liang-Zhu; Xu, Ji-Jun & Zhao, Xu-Yuan
Abstract
Purpose: To investigate the effect of tricyclic neovibsanin scaffold (TCNS) on cell viability, colony
formation capacity and induction of apoptosis in glioma cells.
Methods: 3-(4, 5-Dimethylthiazol-2-yl) 2, 5-diphe¬nyltetrazolium bromide (MTT) assay was used to
analyze the effect of TCNS on cell proliferation. Light microscopic examination of giemsa solution
stained cells was used to calculate the number of colonies with > 50 cells. Flow cytometry using a flow
cytometer, while apoptosis detection kit were used to analyze induction of apoptosis.
Results: TCNS treatment significantly inhibited the viability of U138 NS and U138 AC cells in a
concentration-dependent manner (p < 0.05). TCNS caused 86 % reduction in the capacity of U138 NS
cells to form colonies and led to significant induction of apoptosis. The activation of caspase 3 and
expression of Bax was increased significantly (p < 0.05). Moreover, TCNS treatment increased the
median survival time of mice bearing glioma to 34 days compared to 22 days in untreated mice.
Conclusion: Thus, TCNS treatment significantly inhibits the viability of glioma cells and colony
formation, but induces apoptosis and increases the median survival of mice. Hence, TCNS may be of
therapeutic value for the treatment of glioma.
Keywords
Glioma; Tricyclic neovibsanin scaffold; Survival time; Colony formation; Apoptosis
|
|
© Copyright 2016 - Tropical Journal of Pharmaceutical Research Alternative site location: http://www.tjpr.org
|
|